COVID-19 burden differed by city districts and ethnicities during the pre-vaccination era in Amsterdam, the Netherlands.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 14 02 2023
accepted: 05 06 2023
medline: 11 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

During the first wave of COVID-19 in Amsterdam, the Netherlands, a disproportional number of COVID-19 hospitalizations occurred in individuals with an ethnic minority background and in individuals living in city districts with a lower socioeconomic status (SES). In this study, we assessed whether these disparities continued throughout the second wave, when SARS-CoV-2 testing was available to anyone with symptoms but prior to the availability of COVID-19 vaccination. Surveillance data on all notified SARS-CoV-2 cases in Amsterdam between 15 June 2020 and 20 January 2021 were matched to municipal registration data to obtain the migration background of cases. Crude and directly age- and sex-standardized rates (DSR) of confirmed cases, hospitalizations, and deaths per 100,000 population were calculated overall, and by city districts, and migration backgrounds. Rate differences (RD) and rate ratios (RR) were calculated to compare DSR between city districts and migration backgrounds. We used multivariable Poisson regression to assess the association of city districts, migration backgrounds, age, and sex with rates of hospitalization. A total of 53,584 SARS-CoV-2 cases (median age 35 years [IQR = 25-74]) were notified, of whom 1,113 (2.1%) were hospitalized and 297 (0.6%) deceased. DSR of notified infections, hospitalization, and deaths per 100,000 population were higher in lower SES peripheral city districts (South-East/North/New-West) than higher SES central districts (Central/West/South/East), with almost a 2-fold higher hospitalization DSR in peripheral compared to central districts (RR = 1.86, 95%CI = 1.74-1.97). Individuals with a non-European migration background also had a higher COVID-19 burden, particularly with respect to hospitalization rates, with a 4.5-fold higher DSR for individuals with a non-European background compared to ethnic-Dutch (RR 4.51, 95%CI = 4.37-4.65). City districts, migration backgrounds, male gender, and older age were independently associated with COVID-19 hospitalization rates. Individuals with a non-European background and individuals living in city districts with lower SES continued to independently have the highest COVID-19 burden in the second wave of COVID-19 in Amsterdam, the Netherlands.

Sections du résumé

Background
During the first wave of COVID-19 in Amsterdam, the Netherlands, a disproportional number of COVID-19 hospitalizations occurred in individuals with an ethnic minority background and in individuals living in city districts with a lower socioeconomic status (SES). In this study, we assessed whether these disparities continued throughout the second wave, when SARS-CoV-2 testing was available to anyone with symptoms but prior to the availability of COVID-19 vaccination.
Methods
Surveillance data on all notified SARS-CoV-2 cases in Amsterdam between 15 June 2020 and 20 January 2021 were matched to municipal registration data to obtain the migration background of cases. Crude and directly age- and sex-standardized rates (DSR) of confirmed cases, hospitalizations, and deaths per 100,000 population were calculated overall, and by city districts, and migration backgrounds. Rate differences (RD) and rate ratios (RR) were calculated to compare DSR between city districts and migration backgrounds. We used multivariable Poisson regression to assess the association of city districts, migration backgrounds, age, and sex with rates of hospitalization.
Results
A total of 53,584 SARS-CoV-2 cases (median age 35 years [IQR = 25-74]) were notified, of whom 1,113 (2.1%) were hospitalized and 297 (0.6%) deceased. DSR of notified infections, hospitalization, and deaths per 100,000 population were higher in lower SES peripheral city districts (South-East/North/New-West) than higher SES central districts (Central/West/South/East), with almost a 2-fold higher hospitalization DSR in peripheral compared to central districts (RR = 1.86, 95%CI = 1.74-1.97). Individuals with a non-European migration background also had a higher COVID-19 burden, particularly with respect to hospitalization rates, with a 4.5-fold higher DSR for individuals with a non-European background compared to ethnic-Dutch (RR 4.51, 95%CI = 4.37-4.65). City districts, migration backgrounds, male gender, and older age were independently associated with COVID-19 hospitalization rates.
Discussion
Individuals with a non-European background and individuals living in city districts with lower SES continued to independently have the highest COVID-19 burden in the second wave of COVID-19 in Amsterdam, the Netherlands.

Identifiants

pubmed: 37427262
doi: 10.3389/fpubh.2023.1166193
pmc: PMC10326320
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166193

Informations de copyright

Copyright © 2023 Bachour, Wynberg, Coyer, Buster, Schreijer, van Duijnhoven, van Dam, Prins and Leenstra.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

BMJ. 2020 May 29;369:m2122
pubmed: 32471825
BMC Public Health. 2021 Sep 22;21(1):1721
pubmed: 34551752
EClinicalMedicine. 2021 Mar;33:100805
pubmed: 33754139
Int J Equity Health. 2009 Oct 08;8:35
pubmed: 19814786
Ethn Health. 2009 Jun;14(3):255-69
pubmed: 19052941
BMJ Open. 2021 Jan 4;11(1):e043577
pubmed: 33397669
Open Forum Infect Dis. 2022 May 17;9(6):ofac257
pubmed: 35783684
Lancet. 2021 May 8;397(10286):1711-1724
pubmed: 33939953
Trop Med Int Health. 2020 Mar;25(3):278-280
pubmed: 32052514
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
EClinicalMedicine. 2023 Mar;57:101877
pubmed: 36969795
Stat Med. 1997 Apr 15;16(7):791-801
pubmed: 9131766
Lancet. 2021 Jul 31;398(10298):389-390
pubmed: 34332680
Bus Econ. 2021;56(3):168-178
pubmed: 34253931
SSM Popul Health. 2021 Mar;13:100717
pubmed: 33344747
J Epidemiol Community Health. 2022 Oct 31;:
pubmed: 36316152
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147

Auteurs

Yara Bachour (Y)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Elke Wynberg (E)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Liza Coyer (L)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.
Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Marcel Buster (M)

Department of Epidemiology, Health Promotion and Care Innovation, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Anja Schreijer (A)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Yvonne T H P van Duijnhoven (YTHP)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Alje P van Dam (AP)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Maria Prins (M)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.
Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Tjalling Leenstra (T)

Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH